Fidelity Investments’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $59K | Buy |
25,871
+11,801
| +84% | +$37.4K | ﹤0.01% | 4050 |
|
|
2025
Q4 | $56.3K | Sell |
14,070
-8,735,926
| -100% | -$48.6M | ﹤0.01% | 4046 |
|
|
2025
Q3 | $74M | Buy |
8,749,996
+2,329,612
| +36% | +$22.6M | ﹤0.01% | 1301 |
|
|
2025
Q2 | $72.3M | Buy |
6,420,384
+3,214,251
| +100% | +$29.5M | ﹤0.01% | 1251 |
|
|
2025
Q1 | $30.4M | Sell |
3,206,133
-1,270,349
| -28% | -$12.8M | ﹤0.01% | 1549 |
|
|
2024
Q4 | $50.4M | Buy |
4,476,482
+144,253
| +3% | +$2.54M | ﹤0.01% | 1381 |
|
|
2024
Q3 | $123M | Sell |
4,332,229
-1,793,603
| -29% | -$46.2M | 0.01% | 1016 |
|
|
2024
Q2 | $117M | Sell |
6,125,832
-4,466,402
| -42% | -$114M | 0.01% | 990 |
|
|
2024
Q1 | $347M | Sell |
10,592,234
-2,298,495
| -18% | -$73.3M | 0.02% | 575 |
|
|
2023
Q4 | $426M | Sell |
12,890,729
-3,609,017
| -22% | -$102M | 0.03% | 461 |
|
|
2023
Q3 | $464M | Sell |
16,499,746
-333,559
| -2% | -$9.27M | 0.04% | 413 |
|
|
2023
Q2 | $497M | Buy |
16,833,305
+2,191,606
| +15% | +$70.9M | 0.04% | 429 |
|
|
2023
Q1 | $461M | Buy |
14,641,699
+9,980,971
| +214% | +$316M | 0.04% | 438 |
|
|
2022
Q4 | $131M | Buy |
4,660,728
+42,961
| +0.9% | +$1.23M | 0.01% | 864 |
|
|
2022
Q3 | $166M | Buy |
4,617,767
+108,058
| +2% | +$3.81M | 0.02% | 746 |
|
|
2022
Q2 | $138M | Buy |
4,509,709
+1,076,092
| +31% | +$31.4M | 0.01% | 832 |
|
|
2022
Q1 | $111M | Sell |
3,433,617
-720,733
| -17% | -$18.9M | 0.01% | 1030 |
|
|
2021
Q4 | $115M | Sell |
4,154,350
-993,818
| -19% | -$28.5M | 0.01% | 1041 |
|
|
2021
Q3 | $160M | Buy |
5,148,168
+2,834,086
| +122% | +$68M | 0.01% | 899 |
|
|
2021
Q2 | $48.9M | Buy |
2,314,082
+1,464,050
| +172% | +$29.3M | ﹤0.01% | 1442 |
|
|
2021
Q1 | $17.2M | Buy |
+850,032
| New | +$16.2M | ﹤0.01% | 1851 |
|
|
2020
Q2 | – | Sell |
-8
| Closed | – | – | 3735 |
|
|
2020
Q1 | $0 | Sell |
8
-127
| -94% | -$1.13K | ﹤0.01% | 3783 |
|
|
2019
Q4 | $1K | Sell |
135
-9
| -6% | -$73 | ﹤0.01% | 3639 |
|
|
2019
Q3 | $1K | Sell |
144
-91
| -39% | -$653 | ﹤0.01% | 3636 |
|
|
2019
Q2 | $2K | Sell |
235
-1,323
| -85% | -$15.7K | ﹤0.01% | 3514 |
|
|
2019
Q1 | $20K | Sell |
1,558
-1,713,281
| -100% | -$27.1M | ﹤0.01% | 2971 |
|
|
2018
Q4 | $34.2M | Sell |
1,714,839
-686,987
| -29% | -$15.9M | ﹤0.01% | 1326 |
|
|
2018
Q3 | $68.2M | Buy |
2,401,826
+760,844
| +46% | +$18.1M | 0.01% | 1122 |
|
|
2018
Q2 | $34.5M | Buy |
1,640,982
+216,243
| +15% | +$4.09M | ﹤0.01% | 1463 |
|
|
2018
Q1 | $20.3M | Sell |
1,424,739
-453,136
| -24% | -$6.49M | ﹤0.01% | 1725 |
|
|
2017
Q4 | $23.1M | Sell |
1,877,875
-6,547,350
| -78% | -$92.3M | ﹤0.01% | 1658 |
|
|
2017
Q3 | $150M | Sell |
8,425,225
-1,439,550
| -15% | -$29.7M | 0.02% | 793 |
|
|
2017
Q2 | $250M | Buy |
9,864,775
+5,333,252
| +118% | +$128M | 0.03% | 589 |
|
|
2017
Q1 | $101M | Buy |
4,531,523
+2,289,227
| +102% | +$43.9M | 0.01% | 990 |
|
|
2016
Q4 | $33.2M | Sell |
2,242,296
-224,275
| -9% | -$4.42M | ﹤0.01% | 1481 |
|
|
2016
Q3 | $60.7M | Buy |
2,466,571
+600,780
| +32% | +$14M | 0.01% | 1217 |
|
|
2016
Q2 | $35.8M | Buy |
1,865,791
+189,612
| +11% | +$2.6M | ﹤0.01% | 1420 |
|
|
2016
Q1 | $17.7M | Buy |
1,676,179
+33,900
| +2% | +$350K | ﹤0.01% | 1726 |
|
|
2015
Q4 | $19.9M | Buy |
1,642,279
+27,699
| +2% | +$408K | ﹤0.01% | 1699 |
|
|
2015
Q3 | $25.8M | Buy |
1,614,580
+150,651
| +10% | +$2.94M | ﹤0.01% | 1549 |
|
|
2015
Q2 | $28.5M | Buy |
+1,463,929
| New | +$27.3M | ﹤0.01% | 1586 |
|
Other funds holding EVH
CCM
RF
EC
VCM
RSCM
Fidelity Investments's EVH Position: Q1 2026 in Review
Fidelity Investments increased its Evolent Health (EVH) stake by 84% in Q1 2026, buying an estimated $37.4K and bringing the position to 25,871 shares worth $59K. The position accounts for ﹤0.01% of the portfolio, ranked #4050.
Fidelity Investments first reported a position in EVH in Q2 2015 and has held it in 41 quarters since. The position peaked at $497M in Q2 2023. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.
- Fidelity Investments held 25,871 shares of Evolent Health worth $59K as of Q1 2026.
- Fidelity Investments bought 11,801 Evolent Health shares in Q1 2026, an estimated $37.4K.
- Evolent Health made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #4050 holding.
- Fidelity Investments first reported a position in Evolent Health in Q2 2015 and has held it in 41 quarters since.
- Fidelity Investments's Evolent Health position peaked at $497M in Q2 2023.
- 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.
Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.